91 related articles for article (PubMed ID: 3341785)
1. [Local administration of recombinant interferon-beta to patients with cancer-associated body cavity fluids].
Tanaka N; Terasawa A; Matsui T; Yamada J; Hizuta A; Ichikawa J; Nakayama F; Matsuda T; Orita K
Gan To Kagaku Ryoho; 1988 Feb; 15(2):237-41. PubMed ID: 3341785
[TBL] [Abstract][Full Text] [Related]
2. [Intracavitary administration of recombinant interferon in cancer patients with malignant effusions].
Takashima S; Saeki T; Saeki H; Tanada M; Takiyama W; Kimura T; Moriwaki S
Gan No Rinsho; 1986 Sep; 32(11):1451-7. PubMed ID: 3773273
[TBL] [Abstract][Full Text] [Related]
3. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
4. [Natural beta-interferon for local use in the treatment of metastatic pleural effusion caused by neoplasm of the breast].
Terzoli E; Izzo F; Lucatelli S; Ranuzzi M
G Ital Oncol; 1989; 9(2-3):53-7. PubMed ID: 2767729
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of CDDP administration into the body cavity].
Kikuchi K; Fujisaki M; Tamura T; Takahashi R; Kurihara E; Takada Y; Suito T; Uematsu Y
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3253-8. PubMed ID: 3688890
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with malignancy-associated effusions.
van de Molengraft FJ; Vooijs GP
Acta Cytol; 1989; 33(6):911-6. PubMed ID: 2588923
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion].
Kawaoka T; Yoshino S; Hazama S; Tangoku A; Oka M
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1562-5. PubMed ID: 14619464
[TBL] [Abstract][Full Text] [Related]
8. Positive effusion cytology as the initial presentation of malignancy.
Monte SA; Ehya H; Lang WR
Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
[TBL] [Abstract][Full Text] [Related]
9. Intracavitary beta-interferon for the management of pleural and/or abdominal effusions in patients with advanced cancer refractory to chemotherapy.
Gebbia V; Russo A; Gebbia N; Valenza R; Testa A; Palmeri S; Rausa L
In Vivo; 1991; 5(6):579-81. PubMed ID: 1810442
[TBL] [Abstract][Full Text] [Related]
10. [Intrapleural administration of CDDP against malignant pleural effusions in breast cancer].
Kikuchi K; Tsuyuki A; Fujishiro Y; Utsumi T; Fujisaki M; Kurihara E; Uematsu M
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1905-8. PubMed ID: 2393307
[TBL] [Abstract][Full Text] [Related]
11. [Intraperitoneal administration of beta-interferon in gastric cancer patients with peritoneal recurrence (ascites and serum IFN levels and its antitumor effect)].
Notsuka T; Furusawa M; Tomoda H; Seo Y; Kurashige S; Kameda K; Sonoda T
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3538-40. PubMed ID: 3024584
[No Abstract] [Full Text] [Related]
12. [Response and pharmacokinetics of cisplatin instilled into the pleural cavity].
Kudoh S; Takifugi N; Ryu S; Sakai N; Matsui K; Negoro S; Tamai S; Takada M; Kusunoki Y; Fukuoka M
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2161-5. PubMed ID: 4062316
[TBL] [Abstract][Full Text] [Related]
13. [Effect of human recombinant beta-interferon on natural killer activity of peripheral lymphocytes in cancer patients].
Beika T; Tanaka N; Yamada J; Hizuta A; Onishi K; Akura Y; Hirose K; Orita K
Gan To Kagaku Ryoho; 1985 Feb; 12(2):362-5. PubMed ID: 3970557
[TBL] [Abstract][Full Text] [Related]
14. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion].
Ishimori S; Okada S; Yamagata S; Satoh S
Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of intrapleural or peritoneal repetitive administration of Lentinan and OK-432 for malignant effusion].
Kawaoka T; Yoshino S; Kondo H; Yamamoto K; Hazama S; Oka M
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1565-7. PubMed ID: 16315870
[TBL] [Abstract][Full Text] [Related]
16. The interval between the diagnosis of malignancy and the development of effusions, with reference to the role of cytologic diagnosis.
van de Molengraft FJ; Vooijs GP
Acta Cytol; 1988; 32(2):183-7. PubMed ID: 3348059
[TBL] [Abstract][Full Text] [Related]
17. [Aclacinomycin; benefits for the treatment of malignant pleural effusion].
Homma T; Min KY; Yoneda S; Yoshida S; Nakagawa H
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1810-6. PubMed ID: 6309098
[TBL] [Abstract][Full Text] [Related]
18. [Local administration of adriamycin (ADM) for malignant pleural effusion and pericardiac effusion in breast cancer].
Saisho S; Saeki T; Takashima S; Aogi K; Ohsumi S
Gan To Kagaku Ryoho; 2003 Dec; 30(13):2063-8. PubMed ID: 14712766
[TBL] [Abstract][Full Text] [Related]
19. [Pleuroperitoneal shunt for malignant pleural effusions].
Sadahiro S; Tsumura O; Kubouchi K; Isobe Y; Ohmura T; Yamada Y; Saito T; Takeguchi K
Nihon Gan Chiryo Gakkai Shi; 1989 Jan; 24(1):1-6. PubMed ID: 2738435
[TBL] [Abstract][Full Text] [Related]
20. Endocavitary beta-interferon in neoplastic effusions.
Cherchi PL; Campiglio A; Rubattu A; Desole A; Andria G; Ambrosini A
Eur J Gynaecol Oncol; 1990; 11(6):477-9. PubMed ID: 2086232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
